Navigation Links
Shire Second Quarter Product Sales Up 16%
Date:8/1/2012

ed to, the amount of finished product each party can manufacture (as determined by the US Drug Enforcement Agency), any increase or decrease in market share and / or product discounts on branded and non-branded versions of ADDERALL XR. Whilst there is one generic entrant Shire believes that it will remain competitive in the ADDERALL XR marketplace through the distribution of branded ADDERALL XR and through its two authorized generic partners, Teva Pharmaceuticals Industries Ltd and Impax.

VPRIV - for the treatment of Type 1 Gaucher disease

  • Shire has received a complete response letter from the FDA regarding production of VPRIV drug substance at Lexington. Shire continues to work closely with the FDA to address their questions and resolve any outstanding issues to their satisfaction.

    Notwithstanding the ongoing discussions with the FDA, Shire continues to supply VPRIV to US patients through its existing approved US manufacturing facilities and has the capacity to meet the anticipated demand for VPRIV from existing and new patients both in the US and globally.

Pipeline


Lisdexamfetamine dimesylate ("LDX") for the treatment of ADHD (currently marketed as VYVANSE in the US for the treatment of ADHD)

  • On May 23, 2012 Shire presented results of a Phase 3 study which demonstrated the long-term maintenance of efficacy of LDX in children and adolescents aged 6 to 17 years with ADHD. Results showed maintenance of efficacy in children and adolescents who continued to receive LDX, as demonstrated by a significantly lower proportion of ADHD treatment failures (13.5%) in this group, compared with placebo (65.8%). The majority of placebo-treated subjects who met protocol-defined ADHD symptom relapse criteria did so within two weeks following randomisation. Long-term maintenance therapy plays an important role in the treatment of ADHD. There are ho
    '/>"/>

SOURCE Shire plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related medicine technology :

1. Maroon 5 Lead Singer Adam Levine and Shire Announce "The Own It Project," Encouraging Adults with Attention-Deficit/Hyperactivity Disorder to Tell Their Stories Through a National Contest
2. Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth
3. Shire to Present Scientific Data Across Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting May 5-9
4. Shire Announces that the US Food and Drug Administration has Responded to its Citizen Petition for Adderall XR and has Approved One Abbreviated New Drug Application for Generic Adderall XR
5. Rapid Fire Marketing Funds Development of Second Generation Vapor Inhaler
6. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
7. Avanir Pharmaceuticals Announces Date Of Fiscal 2012 Second Quarter Financial Results And Conference Call
8. The Female Health Company Reports Second Quarter Operating Results
9. Winner Medical Group Inc. to Host Second Quarter 2012 Earning Conference Call on Thursday, May 10, 2012 at 9:00 p.m. EDT
10. Biodel to Report Second Quarter Fiscal Year 2012 Financial Results on May 10, 2012
11. Landauer, Inc. Reports Fiscal 2012 Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 23, 2015  CytoSorbents Corporation (NASDAQ CM: CTSO), a ... cytokine adsorber to reduce deadly inflammation in critically-ill ... $385,642, net of transaction costs, in non-dilutive funding ... Tax Certificate Transfer Program sponsored by the New ...
(Date:1/23/2015)... Jan. 23, 2015 Gem Pharmaceuticals announced today that ... enrolled into the Company,s Phase 2 clinical trial.  This ... Gem,s lead compound, GPX-150 (an investigational medication), in approximately ... disease. Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
(Date:1/23/2015)... 23, 2015 Tianyin Pharmaceutical Inc. (NYSE Amex: ... the development and sale of patented biopharmaceutical medicine, modernized ... ingredients (API) today announced the business and development progress ... 1. Following the September 2014 JCM application (No. ...
Breaking Medicine Technology:CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4
... 14, 2012 The Merz Pharma Group today announced ... of the US holding company, Merz Inc., effective March ... overall responsibility for the Medical Dermatology global business unit ... North American companies: Merz Pharmaceuticals, LLC, Merz Aesthetics, Inc. ...
... Smith, among the nation,s largest pharmaceutical wholesalers, today ... chief financial officer (CFO). Mr. Williams, who served recently ... chairman and chief executive Dale Smith, and joins ... (Photo:  http://photos.prnewswire.com/prnh/20120314/NY69737 ) ...
Cached Medicine Technology:The Merz Pharma Group Appoints William D. Humphries As New North American Chief Executive Officer 2H. D. Smith Appoints Bill Williams Chief Financial Officer 2
(Date:1/22/2015)... 22, 2015 Gabe’s Chemo Duck Program is pleased ... first app ever created for kids with cancer. The Chemo Duck ... devices, is filled with enjoyable games to help children of all ... free app helps to keep kids entertained, educated and at ease ...
(Date:1/22/2015)... 2015 Angelweddingdress is a famous wedding dress ... customers to follow it on Facebook, Twitter, and Pinterest. The ... gift. Angelweddingdress draws a lottery every week. , Moreover, the ... 28, 2015. Click Angelweddingdress homepage for more information. ...
(Date:1/22/2015)... Juvent Sports ( http://www.juventsports.com ) and David Leadbetter ... to bestow a Juvent Sports Achievement award upon an ... The award commemorated and congratulated McKitrick for her record ... her first amateur tournament in 1979 and most recently ...
(Date:1/22/2015)... For over 20 years, Dr. David Cruz of Cruz Chiropractic ... treated just about every type of injury that can result from ... same twenty-plus years, the team at Doctors on Liens ... possible doctor. With the combined breadth of experience between ...
(Date:1/22/2015)... La Jolla, Calif. (PRWEB) January 22, 2015 ... and Assemblymembers Susan Bonilla (D-Concord) and Kristin Olsen ... (CHI) for their leadership in advancing biotechnology, biomedical ... Mitchell, Bonilla and Olsen each received the “2014 ...
Breaking Medicine News(10 mins):Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3
... heart failure rarely occurs among leukemia patients who take ... Anderson Cancer Center found after an exhaustive review of ... in clinical trials for the drug. , Researchers found ... have been caused by heart failure. Of those, 18 ...
... edition of The Journal of Immunology provide key new ... a principal investigator in SBRIs Viral Vaccines Program who ... Medical Center, is senior author on one of three ... symptom of AIDS, is likely a part of a ...
... Universal,Health Realty Income Trust (NYSE: UHT ) ... pay a quarterly dividend of $.575 per share ... of September 17, 2007. Universal Health Realty ... healthcare and human service related facilities including acute,care ...
... 6 ABQAURP is pleased to announce the,2007-08 ... Medical,Errors." The core content includes patient safety initiatives, ... populations,responsibility for error reporting and public education. ... -- serious and,costly errors in the provision of ...
... An Evening with Tim McGraw and Friends, ... Presented by Anheuser-Busch Companies, NAPA, Calif., ... annual fundraising gala on Friday, Nov. 2 at Grant,s Farm,the ... Anheuser-Busch,Companies is sponsoring "Denim & Diamonds: An Evening with Tim ...
... - MaxLife Fund Corp. (OTC:,MXFD), is pleased to announce ... Settlement Policies with a total face value of $4,000,000. ... Settlement,Policies and Portfolios that are available to be purchased. ... the company to profit,and create value for our shareholders. ...
Cached Medicine News:Health News:Study finds heart failure is rare among leukemia patients on imatinib 2Health News:Study finds heart failure is rare among leukemia patients on imatinib 3Health News:SIV infection of natural hosts provides new insights into HIV disease complexity 2Health News:ABQAURP Announces Certificate Course in Medical Error Prevention 2Health News:The Tug McGraw Foundation Announces 2007 Fundraising Gala 2Health News:The Tug McGraw Foundation Announces 2007 Fundraising Gala 3Health News:The Tug McGraw Foundation Announces 2007 Fundraising Gala 4
...
...
...
... Anterior Cervical Plate System allows for ... along slots in the plate, while ... end of the construct. In addition, ... pre-compression features that enable the surgeon ...
Medicine Products: